Clues to quality of journals
Open Access Policy of Helmholtz Association 2016
CC Licencences
Publication Metrics
Home
Deutsch
New EVA Application
Advanced Search
Browse by ...
Publication overview
Statistics (last 5 years)
OA Publications
Submit Publication
Import publication from...
Report missing publication
Contact persons
Help
Text
Endnote (RIS)
BibTeX
DOI
 |
|
as soon as is submitted to ZB.
Monitoring of diabetic late complication.
In: Drug Discovery and Evaluation: Pharmacological Assays. Cham, Switzerland: Springer, 2016. 3071-3117
Secondary symptoms of long-lasting diabetes mellitus are diabetic neuropathy with sensory symptoms, motoric disturbances due to reduced nerve conduction velocity, and diabetic cataracts. Both are related to enhanced conversion of glucose to polyols, such as sorbitol, by the enzyme aldose reductase (van Heyningen 1959; Clements 1979). Sorbitol is converted to fructose by sorbitol dehydrogenase. A low activity of this enzyme enhances the accumulation of sorbitol, thus contributing to cellular damage. Inhibitors of aldose reductase have been developed with positive results in diabetic patients (Kador et al. 1985).
Altmetric
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Edited volume or book chapter
Editors
Hock, F.J.*
Language
Publication Year
2016
HGF-reported in Year
2016
e-ISSN
978-3-319-05392-9
ISBN
978-3-319-05391-2
Book Volume Title
Drug Discovery and Evaluation: Pharmacological Assays
Quellenangaben
Pages: 3071-3117
Publisher
Springer
Publishing Place
Cham, Switzerland
Institute(s)
Institute of Diabetes and Obesity (IDO)
POF-Topic(s)
30201 - Metabolic Health
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502200-001
Scopus ID
84957638251
Erfassungsdatum
2016-02-20